$MRMD: The DEA could remove cannabis from the list of schedule-1 drugs so that the FDA can study it for medical purposes and insurance companies can help patients by reducing the overall cost of medical cannabis through the use of a co-pay similar to picking up a prescription at a pharmacy.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.